293 related articles for article (PubMed ID: 19770328)
1. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
Mannelli L; Kim S; Hajdu CH; Babb JS; Clark TW; Taouli B
AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
[TBL] [Abstract][Full Text] [Related]
4. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
[TBL] [Abstract][Full Text] [Related]
5. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
Fan WJ; Zhang L; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
[TBL] [Abstract][Full Text] [Related]
7. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
[TBL] [Abstract][Full Text] [Related]
9. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
10. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
Xiao YP; Xiao EH; Luo JG; Bian DJ; Li MQ; He Z; Shang QL; Liang B
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):914-6. PubMed ID: 19173992
[TBL] [Abstract][Full Text] [Related]
12. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
[TBL] [Abstract][Full Text] [Related]
13. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
14. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
16. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
[TBL] [Abstract][Full Text] [Related]
17. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
Yu JS; Kim JH; Chung JJ; Kim KW
J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.
Halappa VG; Bonekamp S; Corona-Villalobos CP; Li Z; Mensa M; Reyes D; Eng J; Bhagat N; Pawlik TM; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):285-94. PubMed ID: 22627601
[TBL] [Abstract][Full Text] [Related]
19. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
